Previous Statements by MYGN
» Myriad Genetics Inc. F2Q10 Earnings Conference Call
» Myriad Genetics, Inc F4Q09 (Qtr End 06/30/09) Earnings Call Transcript
» Myriad Genetics F3Q09 (Qtr End 03/31/09) Earnings Call Transcript
Sage Therapeutics, Immunomedics and Myriad Genetics were among the premarket biotech stock movers on Monday.
Cramer points to Gilead's pipeline for its problems.
Those who thought we were ready to break down look foolish again.